David R. McAvoy - Mar 5, 2025 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Chief Legal Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for David R. McAvoy
Stock symbol
TEVA
Transactions as of
Mar 5, 2025
Transactions value $
$0
Form type
4
Date filed
3/7/2025, 04:22 PM
Previous filing
Mar 6, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +56.6K $0.00 56.6K Mar 5, 2025 Ordinary Shares 56.6K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.